The latest research from Fore Pharma, Japan Diabetic Retinopathy Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Diabetic Retinopathy pipeline products, Diabetic Retinopathy epidemiology, Diabetic Retinopathy market valuations and forecast, Diabetic Retinopathy products sales and competitive landscape in Japan.
The research is classified into nine sections – Diabetic Retinopathy overview including etiology, pathophysiology, and diagnosis, Diabetic Retinopathy treatment options, Diabetic Retinopathy pipeline products, Diabetic Retinopathy market analysis comprising of Diabetic Retinopathy epidemiology, key products marketed for Diabetic Retinopathy, market valuations and forecast, products sales and market shares.
Research Scope: - Diabetic Retinopathy Pipeline: Find out the products in clinical trials for the treatment of Diabetic Retinopathy by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Diabetic Retinopathy Epidemiology: Find out the number of patients diagnosed (prevalence) with Diabetic Retinopathy in Japan - Diabetic Retinopathy Products: Identify key products marketed and prescribed for Diabetic Retinopathy in Japan, including trade name, molecule name, and company - Diabetic Retinopathy Product Sales: Find out the sales revenues of Diabetic Retinopathy products, both branded and generics, in Japan - Diabetic Retinopathy Market Valuations: Find out the market size for Diabetic Retinopathy products in 2015 in Japan. Find out how the market advanced from 2010 and forecast to 2020 - Diabetic Retinopathy Products Market Share: Find out the market shares for key Diabetic Retinopathy products in Japan
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Diabetic Retinopathy market analysis and sales trends - Track competitor drugs sales and market share in Japan Diabetic Retinopathy market - Track competitive developments in Diabetic Retinopathy market and present key issues and learnings - Synthesize insights for Diabetic Retinopathy market and products to drive business performance - Answer key business questions about the Diabetic Retinopathy market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Diabetic Retinopathy products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Apr 2021
Major players in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market are Abbott Laboratories, Agilent Technologies Inc., Biomerieux Sa, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd (Roche Diagnostics), Qiagen N.V., Genmark Diagnostics, Thermo Fisher Scientific Inc., General Electric Company (Ge...
KEY FINDINGS The Asia-Pacific peripheral vascular devices market is anticipated to record a CAGR of 11.98% during the forecast period, 2021-2028. The rising prevalence of chronic diseases and the increasing disposable incomes are among the factors that contribute to the market growth. MARKET INSIGHTS India,...
‘Chronic kidney disease (CKD)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Chronic kidney disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
Chronic Kidney Disease (CKD) Understanding
Coca-Cola Plus: Success Case Study
Coca-Cola Plus: Success Case Study, a Food for Specified Health Uses (FOSHU) beverage, in Japan underlines the growing demand for functional beverages in the country.
In 2017, Coca-Cola rolled out a Food for Specified Health Uses (FOSHU)-certified...
Galacto?oligosaccharides (GOS) Market Size, Share & Trends Analysis Report By Application (Food & Beverages, Dietary Supplements), By Region, And Segment Forecasts, 2019 - 2025 The global galacto-oligosaccharides (gos) market size is projected to reach USD 1.58 billion by 2025. It is expected to expand at a CAGR of...
Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders.Its lead product candidate vadadustat is a HIF-PH inhibitor, a regulator...
Toray Industries, Inc. - Product Pipeline Review - 2016
Global Markets Direct’s, ‘Toray Industries, Inc. - Product Pipeline Review - 2016’, provides an overview of the Toray Industries, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Chronic Kidney Disease (CKD) in 19 Major Markets
Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney damage or a glomerular filtration rate...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.